2016
Differential cellular localization of Epstein-Barr virus and human cytomegalovirus in the colonic mucosa of patients with active or quiescent inflammatory bowel disease
CICCOCIOPPO, R.; F. RACCA; L. SCUDELLER; A. PIRALLA; P. FORMAGNANA et al.Základní údaje
Originální název
Differential cellular localization of Epstein-Barr virus and human cytomegalovirus in the colonic mucosa of patients with active or quiescent inflammatory bowel disease
Autoři
CICCOCIOPPO, R.; F. RACCA; L. SCUDELLER; A. PIRALLA; P. FORMAGNANA; L. POZZI; E. BETTI; A. VANOLI; R. RIBONI; Peter KRUŽLIAK; F. BALDANTI a G. R. CORAZZA
Vydání
Immunologic Research, Totowa, Humana Press, 2016, 0257-277X
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30102 Immunology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.905
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/16:00120608
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
Enterocytes; Inflammatory bowel disease; Mucosa; Quantitative real-time PCR; Viral infection
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 5. 5. 2022 14:51, Mgr. Tereza Miškechová
Anotace
V originále
The role of human cytomegalovirus (HCMV) and Epstein-Barr virus (EBV) in the exacerbation of inflammatory bowel disease (IBD) is still uncertain. We prospectively investigated the presence of EBV and HCMV infection in both epithelial and immune cells of colonic mucosa of IBD patients, both refractory and responders to standard therapies, in comparison with patients suffering from irritable bowel syndrome who were considered as controls, by using quantitative real-time polymerase chain reaction, immunohistochemistry and in situ hybridization, in an attempt to assess viral localization, DNA load, life cycle phase and possible correlation with disease activity indexes. We obtained clear evidence of the presence of high DNA loads of both viruses in either enterocytes or immune cells of refractory IBD patients, whereas we observed low levels in the responder group and an absence of detectable copies in all cell populations of controls. Remarkably, the values of EBV and HCMV DNA in inflamed mucosa were invariably higher than in non-inflamed areas in both IBD groups, and the EBV DNA loads in the cell populations of diseased mucosa of refractory IBD patients positively correlated with the severity of mucosal damage and clinical indexes of activity. Moreover, EBV infection resulted the most prevalent either alone or in combination with HCMV, while immunohistochemistry and in situ hybridization did not allow us to distinguish between the different phases of viral life cycle. Finally, as regards treatment, these novel findings could pave the way for the use of new antiviral molecules in the treatment of this condition.